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Abstract
Background: several studies suggest that a decreased thyroid activity might be favourable in oldest-old subjects and that
subclinical thyroid hyperfunction may be detrimental.
Objectives: to verify whether declining levels of circulating thyroid hormones may contribute to longevity.
Design: cross-sectional observational study.
Setting: all subjects were born in Calabria (southern Italy) and their ancestry in the region was ascertained up to the grand-
parents.
Subjects: six hundred and four home-dwelling subjects (301 females, 303 males), divided into three groups: 278 individuals
60–85 years old; 179 children or nieces/nephews of centenarians who are 60–85 years old; 147 individuals older than 85 years.
Methods: thyroid function parameters were measured in the frame of a comprehensive geriatric assessment.
Results: FT3 and FT4 levels were negatively associated with age. Lower levels of FT3, FT4 and TSH were found in centenar-
ians’ children and nieces/nephews with respect to age-matched controls. Indeed, being a relative of centenarians qualiﬁed as an
independent correlate of thyroid parameters.
Conclusions: age-related subtle thyroid hypofunction (either due to a familial component or due to a reset of the thyroid func-
tion occurring between the sixth and the eighth decade of life) appears to be related to longevity.
Keywords: ageing, thyroid, survival, free-triiodothyronine, elderly
Introduction
Several changes in thyroid function are frequently observed
in the elderly [1, 2]. An increased prevalence of serum
thyroid antibodies and clinical and subclinical hypothyroid-
ism has been consistently reported, up to a prevalence of
20% in women older than 60–65 years [3]. The prevalence
of subclinical hyperthyroidism is also increased in aged sub-
jects of both sexes, affecting 1–1.5% of the general
population in iodine-sufﬁcient areas [3] and up to 7–8% in
iodine-deﬁcient areas [4]. Moreover, the coexistence of
several age-associated diseases may account for serum
thyroid hormone and thyroid-stimulating hormone (TSH)
abnormalities characteristic of the non-thyroidal illness
(NTI) syndrome [2]. However, an age-dependent decline of
thyroid function, at least partially independent from associ-
ated NTI, has been documented, particularly in the ninth
decade of life [2, 5].
723Whether and to what extent this phenomenon rep-
resents a physiologic adaptive mechanism to different meta-
bolic needs, or a subtle metabolic change contributing to
the ageing process, remains unclear [6]. Evidences raised in
the last few years support the hypothesis that some degree
of decreased thyroid activity might have favourable effects
in the oldest-old subjects, whereas either clinical or subclini-
cal thyroid hyperfunction may be detrimental [7, 8].
However, the issue of whether such an age-related decrease
in thyroid activity might represent an adaptive mechanism
occurring in the latest decades of life or might onset in
middle-aged subjects, thus contributing to favour longevity,
is still to be settled. Therefore, we aimed at investigating
changes in thyroid hormone status in a group of subjects
aged from 60 to 105 years. In particular, we tried to verify:
(i) whether circulating levels of thyroid hormones reduce
with ageing and (ii) whether their reduction is associated
with extreme longevity.
Methods
Sample
Participants to the study were 604 subjects (303 males and
301 females), divided into three groups.
The ﬁrst group is represented by 278 individuals aged
between 60 and 85 (CG 60–85) not having long-lived
parents; the second group is composed of 179 individuals
aged between 60 and 85 (CR 60–85) who are children or
nieces/nephews of centenarians; ﬁnally, the third group is
represented by 147 individuals aged more than 85 (85+).
The absence of children of centenarians in the CG 60–85
group was ascertained by asking about parent’sa g ea t
death to all the subjects recruited and by double checking
on the lists of Calabrian centenarians obtained from
municipalities of this region. All the subjects were born in
Calabria (southern Italy) and their ancestry in the region
had been ascertained up to the grandparents’ generation.
The sample was recruited in the frame of different
recruitment campaigns carried out by the research group
between 2002 and 2007. Subjects were identiﬁed by
screening of population registers in different municipalities
distributed across the entire Calabria region. Subjects who
were eligible for age (>60 years) were contacted and
asked for participating in the study. Centenarians, their
children and nieces/nephews were collected in the frame
of the European Challenge of Healthy Aging (ECHA)
Project [9]. Study design and questionnaires used are
freely accessible at the following web site: http://biologia.
unical.it/echa/results.htm.
For the present study, 65 subjects were excluded from
the analysis because of TSH values out of range (44 sub-
jects showed TSH<0.27 μlU/ml; 21 subjects had TSH>
4.20 μlU/ml), leaving 539 subjects for the analysis. All the
subjects had given written informed consent to participate
in the study. The study protocol was approved by the
ethical committee at the University of Calabria, Italy.
Measurement of thyroid function parameters
Plasma was obtained from all subjects by centrifugation (at
3000 r.p.m. for 20 min at room temperature) of whole blood
samples collected after an overnight fasting, and it was
stored at −80°C until the assay. Free-triiodothyronine (FT3),
free-thyroxine (FT4) and TSH were measured by
ElectroChemiLuminescence ImmunoAssay (ECLIA) using
Elecsys 2010 analyzer (Hitachi Ltd, Tokyo, Japan). The
normal range was 2.0–4.4 pg/ml for FT3, 0.93–1.70 ng/dl
for FT4 and 0.27–4.20 μIU/ml for TSH. The intra-assay
and inter-assay coefﬁcients of variation were 3.3 and 5.1%
for FT3, 1.6 and 3.5% for FT4 and 8.6 and 8.7% for TSH,
respectively. The lower limit of sensitivity was 0.26 pg/ml
for FT3, 0.023 mg/dl for FT4, and 0.005 μIU/ml for TSH.
Analytic approach and statistical analysis
Comparisons within the three sample groups were per-
formed by contingency tables with chi-square test used for
categorical variables and ANOV A test for continuous ones
followed by multiple comparison test (Dunnett’s test).
Demographic and clinical features were compared among the
groups previously deﬁned. Variables considered in the ana-
lyses were: cognitive function, as measured by age- and
education-adjusted mini-mental state examination (MMSE)
score [10]; depressive symptoms, as ascertained on the basis
of the short form (15 items) of the Geriatric Depression
Scale (GDS) [11]; functional activity, as assessed by using a
modiﬁcation of the Katz’ index of ADL [12]. The assess-
ment was based on what the subject was able to do at the
time of the visit. Health status was ascertained by medical
visit carried out by a geriatrician, who also conducted a struc-
tured interview including questions on common diseases
occurred in the past. The number of diagnoses was also cal-
culated and considered as an overall index of comorbidity.
Multiple regression was used to investigate the relation-
ship between thyroid hormone levels and age and to test
for differences between the mean thyroid hormone levels
of the groups while adjusting for age. The thyroid measures
were used as dependent variables, age was used as a covari-
ate and group as a factor. The interaction between age and
group was included in order to test whether the slopes of
the regression lines were the same. Other possible confoun-
ders, and their interactions with group, were also included
in the regression using a forward stepwise method and
were retained in the model only if they proved to be signiﬁ-
cant. A P-value less than 0.05 was regarded as indicating
statistical signiﬁcance throughout.
All statistical procedures were performed using SPSS
15.0 statistical software package (SPSS Inc, Chicago, IL,
USA).
Results
Demographic and clinical characteristics of subjects divided
according to group membership are reported in Table 1.
Gender distribution was similar in the three groups,
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724whereas cognitive impairment, physical dependency and
depressive symptoms were more frequent among oldest-old
subjects, as well as heart failure and chronic obstructive
pulmonary (COP) disease. On the contrary, diabetes, hyper-
tension, osteoporosis and migraine were more frequent
among subjects aged less than 85. Noteworthy, children or
nieces/nephews of centenarians showed less disability, as
well as a lower incidence of cardiovascular diseases (heart
failure, arrhythmias, stroke, heart attack), migraine and
COP diseases with respect to the age-matched controls.
This group also showed a lower number of diagnosed dis-
eases in comparison with their age peers not belonging to
centenarians’ families.
The mean value of FT3 observed in the whole studied
population was 3.11 pg/ml (SD: 0.71, range 0.94–5.09).
The corresponding ﬁgures for FT4 and TSH were 1.27 ng/
dl (SD: 0.24, range 0.78–2.00) and 1.36 μlU/ml (SD: 0.82,
range 0.27–4.08), respectively.
Table 2 reports the results of the multiple regression
analyses of thyroid hormone levels on age and group mem-
bership (using two indicator variables) and their inter-
actions. From these models, we found that age was
signiﬁcantly associated with a decrease in FT3 and FT4
levels (β=−0.035, P<0.001; β=−0.005, P=0.010,
respectively) but not with TSH (β=−0.002, P=0.700).
However, for FT4, the age-related decline in values was sig-
niﬁcantly lower in the control group than in the CR group
(β=0.008, P=0.037). Overall, children or nieces/nephews
of centenarians had signiﬁcantly lower FT3 (β=−1.602, P
=0.044), FT4 (β=−0.728, P<0.012) and TSH levels (β=
−0.234, P=0.005) than the age-matched subjects who
were not children or nieces/nephews of centenarians.
After adjusting for the possible confounders, the signiﬁ-
cance of group membership effects on hormone levels
resulted to be still statistically signiﬁcant only in children or
nieces/nephews of centenarians group (see Supplementary
data available in Age and Ageing online). In fact, after adjusting
for confounders, children or nieces/nephews of centenarians
had signiﬁcantly lower value for FT3 (β=−0.346, P<0.001)
and FT4 (β=−0.678, P=0.027) than the age-matched sub-
jects who were not children or nieces/nephews of centenar-
ians. In both these models, only the interaction between 85+
group membership and ADL turned out be signiﬁcant. No
confounders and relevant interactions were added into the
TSH regression model by the stepwise procedure.
Discussion
Changes in thyroid hormones metabolism observed in elderly
patients with NTI have been formerly interpreted as a ﬁnalis-
tic mechanism leading to a reduction in catabolic processes
and oxygen consumption in the course of chronic diseases
[13,14].However, ageing per se may be associated with a reset-
ting of thyroid function which resembles the NTI syndrome
[2,5].Indeed, a signiﬁcant age-related reduction in serum total
and free T3 levels has been demonstrated, particularly in non-
agenarians, whereas serum total and free T4 concentrations
did not show any correlation with age [2]. These
........................................
Table 1. Demographic and clinical characteristics of the
three sub-samples
CG 60–85,
n=278
85+,
n= 147
CR 60–85,
n=179
P-value
Males 147 (52.9%) 74 (50.3%) 82 (45.8%) 0.337
MMSE≤23 87 (32.3%) 130 (89.0%) 74 (41.3%) <0.001
GDS>5 95 (36.5%) 50 (42.4%) 50 (28.6%) 0.044
No ADL disability 42 (15.5%) 115 (78.8%) 1 (0.6%) <0.001
FT3 (pg/ml) 3.35 (0.64) 2.55 (0.59) 3.19 (0.65) <0.001*
Free thyroxine (ng/dl) 1.32 (0.26) 1.25 (0.23) 1.21 (0.21) <0.001*
TSH (μlU/ml) 1.39 (0.86) 1.54 (0.89) 1.16 (0.64) <0.001*
Diabetes 53 (19.6%) 15 (10.3%) 26 (14.6%) 0.039
Hypertension 150 (55.6%) 55 (37.7%) 89 (49.7%) 0.002
Angina pectoris 24 (8.9%) 12 (8.3%) 15 (8.5%) 0.975
Heart failure 42 (15.6%) 45 (31.7%) 13 (7.4%) <0.001
Arrhythmias 63 (23.4%) 28 (19.3%) 15 (8.4%) <0.001
Asthma 26 (9.7%) 20 (13.9%) 10 (5.6%) 0.043
COP disease 84 (31.2%) 67 (46.5%) 25 (14.0%) <0.001
Arthritis 195 (72.5%) 106 (73.6%) 144 (81.4%) 0.088
Migraine 60 (22.3%) 13 (9.0%) 15 (8.5%) <0.001
Osteoporosis 67 (24.9%) 22 (15.3%) 34 (19.3%) 0.060
Gastric ulcer 67 (24.9%) 27 (19.3%) 34 (19.3%) 0.263
Stroke 21 (7.9%) 11 (8.5%) 3 (1.9%) 0.024
Heart attack 27 (10.2%) 6 (4.6%) 3 (1.9%) 0.002
Cancer 11 (4.1%) 7 (5.3%) 13 (8.1%) 0.215
Pneumonia 19 (7.1%) 7 (5.4%) 5 (3.1%) 0.210
Number of diagnoses 3.3± 2.03 3.1±2.00 2.4± 1.61 <0.001*
P-values refer to the chi-square test. Abbreviations: CG 60–85, control group;
85+, 85-plus subjects; CR 60–85, centenarians’ relatives.
Dunnett’s multiple comparison test: FT3: CR 60–85 versus CG 60–85, P=
0.017; 85+ versus CG 60–85, P<0.001; Free thyroxine: CR 60–85 versus
CG 60–85, P<0.001; 85+ versus CG 60–85, P=0.007; TSH: CR 60–85
versus CG 60–85, P= 0.009; 85+ versus CG 60–85, P=0.124; number of
diagnoses: CR 60–85 versus CG 60–85, P<0.001; 85+ versus CG 60–85, P
=0.616.
*P-values refer to the ANOVA test.
........................................
Table 2. Multiple regression models of thyroid hormone
levels on age and group membership
Variable Coefficient (β)S E tP -value Lower
95% CI
Upper
95% CI
FT3
Intercept 5.957 0.482 12.349 <0.001 5.010 6.905
Age −0.035 0.007 −5.421 <0.001 −0.048 −0.022
Group=85+ −2.018 1.126 −1.792 0.074 −4.230 0.193
Group=CR −1.602 0.793 −2.020 0.044 −3.159 −0.045
Age *85+ 0.021 0.012 1.670 0.095 −0.004 0.045
Age *CR 0.018 0.011 1.649 0.100 −0.004 0.040
Free thyroxine (FT4)
Intercept 1.731 0.158 10.983 <0.001 1.422 2.041
Age −0.005 0.002 −2.589 0.010 −0.010 −0.001
Group=85+ 0.049 0.052 0.943 0.346 −0.053 0.152
Group=CR −0.728 0.288 −2.528 0.012 −1.293 −0.162
Age *CR 0.008 0.004 2.086 0.037 0.000 0.016
TSH
Intercept 1.564 0.463 3.375 0.001 0.654 2.475
Age −0.002 0.006 −0.385 0.700 −0.015 0.010
Group=85+ 0.204 0.160 1.280 0.201 −0.109 0.517
Group=CR −0.234 0.083 −2.809 0.005 −0.397 −0.070
Asterisk indicates the interaction terms.
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725ﬁndings suggest that age-related reduction of thyroid hor-
mones might occur at advanced ages as a mechanism resetting
metabolic processes to a lower level of oxygen consumption.
The observation that ageing process and hypothyroidism
share an important pathophysiological mechanism (i.e. in both
conditions, basal metabolic rate decreases) [15] seems to
support this hypothesis. Pathophysiological mechanisms
involved in the observed changes in thyroid function include
an age-related decline of hepatic 5′-deiodinase activity [16]and
a reduction in TSH secretion from the pituitary gland [2, 17].
However, it has recently been demonstrated that common
genetic variations in deiodinase 1 (DIO1) gene can alter deio-
dinase function, resulting in an alteration in the balance of cir-
culating FT3 to FT4 [18]. This ﬁnding could provide a
valuable tool to evaluate genetic factors affecting thyroid
hormone levels and age-associated diseases in the course of
the ageing process, and the study of the DIO1 expression in
elderly subjects warrants further investigation.
Our results conﬁrm the existence of an age-related
decrease in the circulating FT3 levels [2]. On the other hand,
we demonstrated for the ﬁrst time that the negative depen-
dence between age and FT3 levels is speciﬁcally observed in
the group of subjects aged 60–85 but not in the group of
people older than 85 years. In 85+ subjects, however, we
found that the levels of circulating thyroid hormones are sig-
niﬁcantly lower than those in younger subjects. This ﬁnding
may indicate that the decrease in circulating FT3 might
speciﬁcally occur before reaching the ninth decade of life to
adapt metabolic processes and to favour longevity.
A different, complementary, perspective may be given by
the analysis of the group of 60–85 years subjects who are
children or nieces/nephews of centenarians (CR group). In
line with the life-long sustained survival advantage of cente-
narians’ relatives, well documented in the literature [19], we
observed that children or nieces/nephews of centenarians
have less disability, as well as a low prevalence of cardiovas-
cular diseases, migraine and COP diseases with respect to
the age-matched controls. On the other hand, we found that
of centenarians’ relatives have reduced FT3, FT4 and TSH
levels when compared with age-matched subjects who are
not relatives of centenarians. The ﬁnding that CR group is
characterized by less comorbidity and low levels of thyroid
parameters with respect to CG group seems to deny the
interpretation that observed differences in thyroid function
are due simply to chronic NTI and raise the possibility that
low levels of thyroid parameters may be partly genetically
determined. In keeping with such a hypothesis, the
age-related decrease of FT3 could also be interpreted as a
demographic selection favouring the subjects with low levels
of thyroid hormones. Such an interpretation seems to be in
agreement with a recent observation that middle-aged off-
spring of nonagenarian siblings have low circulating concen-
trations of FT3 with respect to their middle-aged partners
[20]. Further supporting this view is the knowledge that her-
itability may contribute to determine not only TSH levels
[21,22],but somewhat FT4 and FT3 levels [22].
The ﬁndings from the present study have important
interpretative implications. Indeed, our results indicate that
age-associated changes in thyroid function might represent
a physiological mechanism directly contributing to the
ageing process through a resetting of the hormonal milieu
which may favour successful ageing and longevity, rather
than an adaptation to the need of reducing the catabolic
processes and oxygen consumption. Such a conceptual fra-
mework is in agreement with previous studies showing that
elderly subjects with low serum FT3 and FT4 concen-
trations had longer survival, especially in the presence of
normal reverse T3 concentrations [7]. If conﬁrmed, this
interpretation would implicate that subtle hypothyroid
status should be considered as a marker of robustness,
while either clinical or subclinical hyperthyroidism, which
are known to exert a detrimental effect on survival, physical
performance, cognitive status and bone mineral content
[8, 23–25],should ﬁnd a place among the markers of frailty.
Limitations of this study should be considered. First, the
cross-sectional design of our study does not allow us to
assess prospectively the impact of thyroid hormone status
on survival. Although this issue deserves further investi-
gation, results obtained in relatives of centenarians are sug-
gestive of a thyroid resetting which could favour longevity.
Second, as only patients with thyroid hormone values within
the normal range were included in the analysis, the current
study is unable to clarify whether subclinical hypothyroidism
also represents a marker of longevity or it rather would
beneﬁt from replacement therapy. However, there is lack of
sufﬁcient evidence to recommend routine treatment for
patients with subclinical hypothyroidism [26], and this issue
warrants further investigation. Finally, being reverse T3 not
measured, subjects carrying a catabolic state characterized by
low FT3 and high reverse T3, which are known to be at risk
of functional decline [7], cannot be identiﬁed in our study.
In conclusion, our study shows that healthy ageing and
longevity are favoured by low levels of thyroid hormones.
Familiarity seems to have a role in determining low levels
of these hormones. In addition, ageing showed to be
associated with relevant changes in thyroid function.
Age-related subtle thyroid hypofunction may onset between
the sixth and the eighth decade of life as a ﬁnalistic mech-
anism favouring successful longevity.
Key points
• FT3 levels in old subjects are negatively associated with
age.
• Relatives of centenarians who are 60–85 years old have
signiﬁcantly reduced FT3, FT4 and TSH levels than age-
matched controls.
• Down-regulation of thyroid hormones, due to either
genetic predisposition or resetting of thyroid function,
favours longevity.
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